{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:40:54Z","timestamp":1791726054546,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.idnow.2024.104941","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:09:56Z","timestamp":1719446996000},"page":"104941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Tumor necrosis factor-alpha antagonists in patients with complicated spinal tuberculosis: A case series and literature review"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6239-2105","authenticated-orcid":false,"given":"Aayesha J.","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashvir","family":"Rugbeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Rozmiarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abi","family":"Manesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8050-9610","authenticated-orcid":false,"given":"Suzaan","family":"Marais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idnow.2024.104941_b0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/cid\/ciy020","article-title":"Spinal tuberculosis: clinicoradiological findings in 274 patients","volume":"67","author":"Marais","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.idnow.2024.104941_b0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2014.03.025","article-title":"Paradoxical reaction in HIV negative tuberculous meningitis","volume":"340","author":"Garg","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.idnow.2024.104941_b0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijid.2018.11.366","article-title":"Paradoxical reaction in HIV-negative tuberculous meningitis patients with spinal involvement","volume":"79","author":"Liu","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.idnow.2024.104941_b0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/cid\/cis899","article-title":"Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome","volume":"56","author":"Marais","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2024.104941_b0025","doi-asserted-by":"crossref","first-page":"292","DOI":"10.12688\/wellcomeopenres.16474.2","article-title":"Host directed therapies for tuberculous meningitis","volume":"5","author":"Davis","year":"2021","journal-title":"Wellcome Open Res"},{"issue":"43","key":"10.1016\/j.idnow.2024.104941_b0030","doi-asserted-by":"crossref","first-page":"e22626","DOI":"10.1097\/MD.0000000000022626","article-title":"Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis: case report and review","volume":"99","author":"Santin","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.idnow.2024.104941_b0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijid.2014.12.030","article-title":"Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis","volume":"32","author":"Bell","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.idnow.2024.104941_b0040","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1093\/cid\/ciaa1826","article-title":"Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort","volume":"72","author":"van Toorn","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idnow.2024.104941_b0045","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/cid\/ciad401","article-title":"Effectiveness of adjunctive high-dose infliximab therapy to improve disability-free survival among patients with severe central nervous system tuberculosis: a matched retrospective cohort study","volume":"77","author":"Manesh","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idnow.2024.104941_b0050","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/jpids\/piab094","article-title":"Infliximab for paradoxical reactions in pediatric central nervous system tuberculosis","volume":"10","author":"Abo","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.idnow.2024.104941_b0055","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa604","article-title":"Use of infliximab to treat paradoxical tuberculous meningitis reactions","author":"Marais","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"10.1016\/j.idnow.2024.104941_b0060","doi-asserted-by":"crossref","first-page":"e235511","DOI":"10.1136\/bcr-2020-235511","article-title":"Potential disease trigger as a therapeutic option: infliximab for paradoxical reaction in tuberculosis of the central nervous system","volume":"14","author":"Briner","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"9","key":"10.1016\/j.idnow.2024.104941_b0065","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/QAD.0000000000000634","article-title":"Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS","volume":"29","author":"Richaud","year":"2015","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.idnow.2024.104941_b0070","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/ene.13732","article-title":"Clinical perspectives into the use of thalidomide for central nervous system tuberculosis","volume":"25","author":"Keddie","year":"2018","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.idnow.2024.104941_b0075","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.96.10.5657","article-title":"Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system","volume":"96","author":"Tsenova","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.idnow.2024.104941_b0080","doi-asserted-by":"crossref","first-page":"G612","DOI":"10.1152\/ajpgi.90576.2008","article-title":"Infliximab and the TNF-alpha system","volume":"296","author":"Ebert","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"10.1016\/j.idnow.2024.104941_b0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10096-023-04564-2","article-title":"The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review","volume":"42","author":"Armange","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6 Suppl 28","key":"10.1016\/j.idnow.2024.104941_b0090","first-page":"S152","article-title":"Side effects of anti-TNF therapy: current knowledge","volume":"20","author":"Antoni","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.idnow.2024.104941_b0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/08830180801911339","article-title":"Thalidomide: mechanisms of action","volume":"27","author":"Paravar","year":"2008","journal-title":"Int Rev Immunol"},{"issue":"4","key":"10.1016\/j.idnow.2024.104941_b0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/08830738060210040801","article-title":"Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases","volume":"21","author":"Schoeman","year":"2006","journal-title":"J Child Neurol"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T07:53:10Z","timestamp":1725090790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991924001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2666991924001088"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104941","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor necrosis factor-alpha antagonists in patients with complicated spinal tuberculosis: A case series and literature review","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104941"}}